Combined clozapine and valproic acid treatment-induced agranulocytosis.
Madeb
R
R
Hirschmann
S
S
Kurs
R
R
Turkie
A
A
Modai
I
I
D000380:Agranulocytosis / Q000139:chemically induced*; D000927:Anticonvulsants / Q000009:adverse effects*; D002908:Chronic Disease; D003024:Clozapine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008875:Middle Aged; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D012702:Serotonin Antagonists / Q000009:adverse effects*; D014635:Valproic Acid / Q000009:adverse effects*
D000927:Anticonvulsants; D012702:Serotonin Antagonists; D014635:Valproic Acid; D003024:Clozapine